in Australia the trademarked supplement ingredient dynamine (methylliberine) is considered to be a prohibited stimulant, but such substances are not yet targeted in the scope of WADA drug testing
Unfortunately, this trial did not pass Phase I with five of the seven enrolled patients experiencing serious adverse effects, including supraventricular tachycardia, convulsion, and pulmonary embolism
This makes it a safer and more promising option for long-term studies (5)
So if you have knowledge of a given cancer or you're concerned, about tumors at all, I would encourage you to be very cautious about the use of BPC-157
BPC 157 also appears to stimulate the expression of growth factors involved in tissue regeneration
Seiwerth S., Milavic M., Vukojevic J., et al